Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects

American Journal of the Medical Sciences

Volumn 331, Issue 2, 2006, Pages 65-71

  Cherng, Zee Chuang ^a   Boyles, Adrienne ^a   Legardeur, Barbara ^a   Su, Joseph ^b   Japa, Shanker ^c   Lopez S, Alfredo ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c General Clinical Research Center New Orleans   (United States)

Author keywords

Folic acid; Homocysteine; Intervention; Methylenetetrahydrofolate reductase; Riboflavin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FATTY ACID; FOLIC ACID; HOMOCYSTEINE; RIBOFLAVIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; METABOLISM; NORMAL HUMAN; VITAMIN SUPPLEMENTATION;

EID: 33646100519     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200602000-00011     Document Type: Article

References (31)

1. Mangoni AA, Jackson SHD. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 2002;112:556-65.
2. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-19.
3. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risks of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-29.
4. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
5. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-98.
6. Ubbink JB, Vermaak WJ, van der Merwe A, et al. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
7. den Heijer M, Brouwer IA, Bos GMJ, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol 1998;18:356-61.
8. Hustad S, Ueland PM, Vollset SE, et al. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000;46:1065-71.
9. Jacques PF, Kalmbach R, Bagley PJ, et al. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 2002;132:283-8.
10. McNulty H, McKinley MC, Wilson B, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 2002;76:436-41.
11. Skoupy S, Fodinger M, Veitl M, et al. Riboflavin is a determinant of total homocysteine plasma concentration in end-stage renal disease patients. J Am Soc Nephrol 2002;13: 1331-7.
12. Moat SJ, Ashfield-Watt PAL, Powers HJ, et al. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 2003;49:295-302.
13. Lakshmi AV, Ramalakshmi BA. Effect of pyridoxine or riboflavin supplementation on plasma homocysteine levels in women with oral lesions. Natl Med J India 1998;1:171-2.
14. McKinley MC, McNulty H, McPartlin J, et al. Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status. Euro J Clin Nutr 2002;56:850-6.
15. Fortin LJ, Genest J Jr. Measurement of homocysteine in the prediction of arteriosclerosis. Clin Biochem 1995;28:155-62.
16. Bayoumi RA, Rosalki SB. Evaluation of methods of coenzyme activation of erythrocyte enzymes for deficiency of vitamin B1, B2, and B6. Clin Chem 1976;22:327-35.
17. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
18. Bates CJ, Fuller NJ. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC1.5.1.20) and folate metabolism in the rat. Br J Nutr 1986;55:455-64.
19. McCormick DB. Two interconnected B vitamins: riboflavin and pyridoxine. Physiol Rev 1989;69:1170-98.
20. Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for cloning and mapping of NADPH-dependent methionine synthase activation. J Biol Chem 2001;276:35558-63.
21. Jacques PF, Bostom AG, Wilson PWF, et al. Determinants of plasma total homocysteine concentration in the Framingham offspring cohort. Am J Clin Nutr 2001;73:613-21.
22. Ganji V, Kafai M. Frequent consumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes of dietary folate and riboflavin but not vitamin B-12 and B-6 are inversely associated with serum total homocysteine concentrations in the US population. Am J Clin Nutr 2004;80:1500-7.
23. Homocysteine Lowering Trials' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 1998;316:894-8.
24. Rader JI. Folic acid fortification, folate status and plasma homocysteine. J Nutr 2002;132:S2466-70.
25. Backstrand JR. The history and future of food fortification in the United States: a public health perspective. Nutr Rev 2002;60:15-26.
26. Jacques PF, Bostom AG, Williams RR, et al. Relationship between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
27. Guttormsen AB, Ueland PM, Nesthus I, et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/L): the Hordaland Homocysteine Study. J Clin Invest 1996;98:2174-83.
28. Kim KN, Kim KJ, Chang N. Effects of the interaction between the C677T 5,10-methelenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. Eur J Clin Nutr 2004;58:10-6.
29. Stern LL, Shane B, Bagley PJ, et al. Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation. J Nutr 2003;133:2716-20.
30. Kimura M, Umegaki K, Higuchi M, et al. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genomic stability in cultured human lymphocyte. J Nutr 2004;134:48-56.
31. De Vriese AS, Verbeke F, Schrijvers BF, et al. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int 2002;61:1199-209.